Executive Summary
This digest covers a single HHS contract record totaling $37,410,472 in obligations, with zero defense-related awards, so the entire data set is civilian. The sole award went to OptumServe Technology Services, Inc., a UnitedHealth Group subsidiary, through a not-competed firm-fixed-price definitive contract from HRSA for COVID-19 Uninsured and Provider Relief Fund close-out services.
The dominant theme is the wind-down of pandemic-era federal program spending, which the close-out framing suggests is in a declining phase. The highest-conviction signal is that roughly 83% of the obligation ($31,134,054) has already been outlaid, indicating the work is largely complete and the revenue run-rate is likely tapering. The key watch item is whether the unused option value (ceiling of $43,783,168 versus $37,410,472 obligated) is exercised and whether the 2027-01-11 current end date is extended.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All HHS Contracts digest from October 01, 2026.
Investment Signals (3)
- OptumServe (UnitedHealth Group) HRSA COVID-19 Close-Out Award of $37.4M Signals Pandemic Program Wind-Down (MEDIUM)▲
The $37,410,472 award from HRSA is framed as close-out services for COVID-19 Uninsured and Provider Relief Fund programs, consistent with declining pandemic-related federal revenue. With $31,134,054 already outlaid, the remaining obligation is limited to roughly $6.3M.
- OptumServe Contract Is Modest Relative to UnitedHealth Group Scale (HIGH)▲
The award is a narrow, not-competed services engagement, and its materiality to the parent appears limited based on the data provided. No aggregate revenue figure for UnitedHealth Group is included in the analysis, so the proportional impact cannot be fully quantified.
- Unused Option Value of $6.4M Creates Possible Upside If Exercised (LOW)▲
The base-plus-options ceiling of $43,783,168 exceeds the $37,410,472 obligation by about $6.4M, which could be added if options are exercised. Exercise would extend near-term revenue beyond current obligations.
Risk Flags (3)
- Budget [MEDIUM RISK]▼
HRSA pandemic close-out work is tied to COVID-19 program wind-down, creating revenue declines as federal pandemic funding ends; the data does not include HRSA budget trend figures to confirm the pace of decline.
- Competition [LOW RISK]▼
The award was not competed, so it is not an indicator of competitive positioning; the competition signal for follow-on work is unknown.
- Execution [LOW RISK]▼
Outlays of $31,134,054 against a $37,410,472 obligation indicate progress, but remaining close-out work must complete on schedule through the 2027 end dates.
Opportunities (2)
- ◆
OptumServe's sole-source position on HRSA close-out work could extend into adjacent program-administration scopes if HRSA issues follow-on requirements.
- ◆
NAICS 541611 and PSC R410 coding indicates a consulting and program-administration focus, which may position OptumServe for other HHS program-evaluation work beyond pandemic close-out.
Sector Themes (1)
- ◆
The $37,410,472 OptumServe award is structured as COVID-19 close-out services, with $31,134,054 already outlaid, consistent with pandemic-related federal spending tapering. This is the only record in the period, so the theme rests on a single data point.
Watch List (2)
- 👁
{"entity" => "UnitedHealth Group Incorporated", "reason" => "Parent of OptumServe; the $37.4M HRSA close-out award is modest relative to the parent's scale and appears low in materiality.", "trigger" => "Option exercise on the $43,783,168 ceiling or any new HHS award to OptumServe"}
- 👁
{"entity" => "OptumServe Technology Services, Inc.", "reason" => "Sole recipient in this period; $31.1M of $37.4M already outlaid, with remaining close-out work through 2027.", "trigger" => "Modifications to the 2027-01-11 current end date or 2027-04-11 potential end date, and any successor HRSA solicitation"}
Get daily alerts with 3 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All HHS Contracts
🇺🇸 More from United States
View all →October 04, 2026
High-Value Federal Grants ($5M+) — October 04, 2026
High-Value Federal Grants ($5M+)
October 04, 2026
Mega Contracts Monitor ($100M+) — October 04, 2026
Mega Contracts Monitor ($100M+)
October 04, 2026
General Federal Contracts — October 04, 2026
General Federal Contracts
October 03, 2026
All NASA Contracts — October 03, 2026
All NASA Contracts